The Discounted Cash Flow (DCF) valuation of Jeil Pharma Holdings Inc (002620.KS) is (38,040.45) KRW. With the latest stock price at 8,820.00 KRW, the upside of Jeil Pharma Holdings Inc based on DCF is -531.3%.
Based on the latest price of 8,820.00 KRW and our DCF valuation, Jeil Pharma Holdings Inc (002620.KS) is a sell. selling 002620.KS stocks now will result in a potential gain of 531.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.9% | 6.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | (100,116.97) - (26,515.07) | (38,040.45) |
| Upside | -1235.1% - -400.6% | -531.3% |